Related Experiment Videos
Dexamethasone as adjuvant therapy for severe acute pharyngitis
J F O'Brien1, J L Meade, J L Falk
1Department of Emergency Medicine, Orlando Regional Medical Center, Florida.
Annals of Emergency Medicine
|February 1, 1993
Summary
Dexamethasone significantly improved pain relief in severe acute exudative pharyngitis patients. This adjuvant therapy offered faster onset and greater pain reduction compared to placebo.
Area of Science:
- Emergency Medicine
- Pharmacology
Background:
- Severe acute exudative pharyngitis often causes significant pain and dysphagia.
- Effective pain management is crucial for patient recovery and well-being.
Purpose of the Study:
- To evaluate the efficacy of dexamethasone as an adjunctive therapy for pain relief in patients with severe acute exudative pharyngitis.
Main Methods:
- A prospective, randomized, double-blinded, placebo-controlled trial was conducted in an urban emergency department.
- Patients aged 12-65 with severe pharyngitis received standard antibiotics plus either a single-dose dexamethasone injection or a placebo.
- Pain was assessed using a visual analog scale at baseline and 24 hours, with longer-term follow-up for complete pain resolution.
Main Results:
- Dexamethasone group showed a significantly greater improvement in pain scores at 24 hours compared to placebo (1.8 vs 1.2, P < .05).
- The onset of pain relief was faster with dexamethasone (6.3 hours vs 12.4 hours, P < .01).
- Time to complete pain resolution was also significantly shorter in the dexamethasone group (15.0 hours vs 35.4 hours, P < .02), with no observed complications.
Conclusions:
- Single-injection dexamethasone is an effective adjuvant therapy for severe acute exudative pharyngitis.
- It provides statistically and clinically significant improvements in pain relief, including faster onset and greater reduction.
- Dexamethasone offers a safe and beneficial option for managing pain in these patients.